MA
IONS icon

MUFG Americas’s Ionis Pharmaceuticals IONS Stock Holding History

MUFG Americas’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-300
Closed -$15K – 1180
2017
Q2 		$15K Hold
300
– – ﹤0.01% 766
2017
Q1 		$12K Sell
300
-1,500
-83% -$67.4K ﹤0.01% 815
2016
Q4 		$86K Buy
+1,800
New +$71.2K ﹤0.01% 516
2015
Q3 		– Sell
-75
Closed -$4K – 1196
2015
Q2 		$4K Buy
+75
New +$4.77K ﹤0.01% 1002
2013
Q4 		– Sell
-400
Closed -$15K – 1140
2013
Q3 		$15K Sell
400
-1,200
-75% -$35.8K ﹤0.01% 938
2013
Q2 		$43K Buy
+1,600
New +$34K ﹤0.01% 1178

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

MUFG Americas's IONS Position: Q3 2017 in Review

MUFG Americas sold out of Ionis Pharmaceuticals (IONS) in Q3 2017, closing a stake of 300 shares — an estimated $15K sold.

MUFG Americas first reported a position in IONS in Q2 2013 and held it in 6 quarters. The position peaked at $86K in Q4 2016. 301 funds tracked by Wall St. Rank hold IONS as of Q3 2017.

  • MUFG Americas reported no remaining Ionis Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • MUFG Americas sold 300 Ionis Pharmaceuticals shares in Q3 2017, an estimated $15K.
  • MUFG Americas first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • MUFG Americas's Ionis Pharmaceuticals position peaked at $86K in Q4 2016.
  • 301 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2017.

Based on MUFG Americas's 13F filing for Q3 2017, filed 13 Nov 2017.